Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Tauopathy is a neurodegenerative disease characterized by the accumulation of abnormal tau proteins.
• The hTau mouse model is used to study tauopathy and its effects on neuronal function.
• Understanding gene expression changes in tauopathy is crucial for developing effective treatments.

Purpose of the Study:

• To investigate gene expression changes in hippocampal CA1 neurons of the hTau mouse model.
• To assess the progression of synaptic dysfunction in hTau mice.
• To validate gene expression findings at the protein level.

Main Methods:

• Laser capture microdissection of CA1 pyramidal neurons.
• RNA amplification, custom microarray analysis, and qPCR validation.
• Confocal microscopy and immunoblot analysis for protein validation.

Main Results:

• Approximately 8% of genes were dysregulated in hTau mice, with significant downregulation of synaptic markers (e.g., synaptophysin, PSD-95).
• Progressive synaptic alterations were observed with increasing age in hTau mice.
• Protein-level validation confirmed decreased expression of key synaptic proteins.

Conclusions:

• The hTau mouse model exhibits tau-induced synaptodegeneration.
• Progressive synaptic dysfunction is a key feature of tau pathology.
• These findings offer insights into synaptic transmission deficits in Alzheimer's disease (AD).